Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
Clinical trial NCT03930771 · TERMINATED
Trial details
- NCT number
- NCT03930771
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-21
- Primary completion
- 2021-08-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.